| 000 | 01840 a2200565 4500 | ||
|---|---|---|---|
| 005 | 20250513112330.0 | ||
| 264 | 0 | _c19970310 | |
| 008 | 199703s 0 0 eng d | ||
| 022 | _a0194-911X | ||
| 024 | 7 |
_a10.1161/01.hyp.29.1.58 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHirata, Y | |
| 245 | 0 | 0 |
_aReceptor subtype for vasopressin-induced release of nitric oxide from rat kidney. _h[electronic resource] |
| 260 |
_bHypertension (Dallas, Tex. : 1979) _cJan 1997 |
||
| 300 |
_a58-64 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAntidiuretic Hormone Receptor Antagonists |
| 650 | 0 | 4 |
_aArginine Vasopressin _xmetabolism |
| 650 | 0 | 4 |
_aBenzazepines _xpharmacology |
| 650 | 0 | 4 | _aDesoxycorticosterone |
| 650 | 0 | 4 |
_aDinoprost _xpharmacology |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aKidney _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNitric Oxide _xmetabolism |
| 650 | 0 | 4 | _aPerfusion |
| 650 | 0 | 4 |
_aPiperidines _xpharmacology |
| 650 | 0 | 4 |
_aQuinolones _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aReceptors, Vasopressin _xclassification |
| 650 | 0 | 4 |
_aRenal Agents _xmetabolism |
| 650 | 0 | 4 |
_aomega-N-Methylarginine _xpharmacology |
| 700 | 1 | _aHayakawa, H | |
| 700 | 1 | _aKakoki, M | |
| 700 | 1 | _aTojo, A | |
| 700 | 1 | _aSuzuki, E | |
| 700 | 1 | _aNagata, D | |
| 700 | 1 | _aKimura, K | |
| 700 | 1 | _aGoto, A | |
| 700 | 1 | _aKikuchi, K | |
| 700 | 1 | _aNagano, T | |
| 700 | 1 | _aHirobe, M | |
| 700 | 1 | _aOmata, M | |
| 773 | 0 |
_tHypertension (Dallas, Tex. : 1979) _gvol. 29 _gno. 1 Pt 1 _gp. 58-64 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/01.hyp.29.1.58 _zAvailable from publisher's website |
| 999 |
_c9027797 _d9027797 |
||